Jump to content

Mahidol University: Dengue fever vaccine expected in five years


webfact

Recommended Posts

Can't say on which Farang TV news channel it was (TV5 Monde?) this morning that a vaccine against Dengue fever had been tested out, in Europe..., and was soon going to be produced by Sanofi (in 3 injections, not for children, only for people living in infested areas)...

Could there be a link with this annoucement by Mahidol? That they are well aware of this news and attempt to pull to themselves the little bit of the rug which might be left, not to become at once 'redundant', after 6 years of research, and spent investments, but still not having started human testing, far from ready to enter the test production phase in a lab, not even speaking of an industrial phase?

Vaccines are multi Billions of US$ businesses, one of the most profitable of the pharmaceutical industry, so it's a permanent race for research labs, and like in all races, there are winners, and...

French vaccine developed jointly with Mexico.... Pipped the Thais to the post and prompted this rather sad response from Mahidol. Al-Jazeera has been running quite a long news story about it.

The Sanofi vaccine, only around 60% effective in its current form, has already been approved in Mexico (reported in the UK Guardian today) Mexico approves first vaccine against dengue virus:

Mexican health authorities have approved the first vaccine to gain official acceptance for use against the dengue virus, which infects about 100 million people every year, mostly in Asia, Africa and Latin America.

Mexico’s federal medical safety agency said Wednesday the vaccine has undergone testing on over 40,000 patients worldwide. It said Wednesday the vaccine’s manufacturer had proved its safety and effectiveness, but did not name the drug.

In a separate statement, the Lyon, France-based Sanofi Pasteur identified the vaccine as Dengvaxia.

Mexico said the vaccine is aimed at people aged nine to 45, and will be used in areas where the disease is endemic.

According to a World Health Organization report published in late 2014, the vaccine had an average rate of effectiveness of about 60.8% in protecting against the four strains of dengue currently circulating.

But it appeared to be particularly effective in protecting people who had already been exposed to one of the four strains from catching another strain.

Link to comment
Share on other sites

Can't say on which Farang TV news channel it was (TV5 Monde?) this morning that a vaccine against Dengue fever had been tested out, in Europe..., and was soon going to be produced by Sanofi (in 3 injections, not for children, only for people living in infested areas)...

Could there be a link with this annoucement by Mahidol? That they are well aware of this news and attempt to pull to themselves the little bit of the rug which might be left, not to become at once 'redundant', after 6 years of research, and spent investments, but still not having started human testing, far from ready to enter the test production phase in a lab, not even speaking of an industrial phase?

Vaccines are multi Billions of US$ businesses, one of the most profitable of the pharmaceutical industry, so it's a permanent race for research labs, and like in all races, there are winners, and...

French vaccine developed jointly with Mexico.... Pipped the Thais to the post and prompted this rather sad response from Mahidol. Al-Jazeera has been running quite a long news story about it.

The Sanofi vaccine, only around 60% effective in its current form, has already been approved in Mexico (reported in the UK Guardian today) Mexico approves first vaccine against dengue virus:

Mexican health authorities have approved the first vaccine to gain official acceptance for use against the dengue virus, which infects about 100 million people every year, mostly in Asia, Africa and Latin America.

Mexico’s federal medical safety agency said Wednesday the vaccine has undergone testing on over 40,000 patients worldwide. It said Wednesday the vaccine’s manufacturer had proved its safety and effectiveness, but did not name the drug.

In a separate statement, the Lyon, France-based Sanofi Pasteur identified the vaccine as Dengvaxia.

Mexico said the vaccine is aimed at people aged nine to 45, and will be used in areas where the disease is endemic.

According to a World Health Organization report published in late 2014, the vaccine had an average rate of effectiveness of about 60.8% in protecting against the four strains of dengue currently circulating.

But it appeared to be particularly effective in protecting people who had already been exposed to one of the four strains from catching another strain.

I thought there were five strains.

Link to comment
Share on other sites

"......... Immunity occurred 14 to 28 days after vaccination and could last for up to five to 10 years, he said."

How can you know it lasts ten years if you've only been testing it for a few years?

You can estimate it from the amount of anti-bodies.

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.










×
×
  • Create New...